JPRN-UMIN000028350已完成未知
Tipepidine in children with Autism Spectrum Disorder : a 4-week, open-label, preliminary study - Tipepidine in children with Autism Spectrum Disorder
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 6years-old 至 17years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with a previous hypersensitivity to Tipepidine Hibenzate. 2.Patients treated with typical antipsychotics and selective norepinephrine reuptake inhibitor (NRI) except atomoxetine and stimulants except methylphenidate. 3.Pregnant or breast-feeding women
研究者
相似试验
已完成
1 期
Tipepidine in children with attention deficit/hyperactivity disorder (AD/HD): a Double-blind, Placebo-controlled TrialAttention deficit/hyperactivity disorder (AD/HD)JPRN-UMIN000015748Department of Psychiatry, Chiba University School of Medicine80
已完成
1 期
Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled TrialAttention Deficit Disorder With Hyperactivity DiseaseHyperkinesisAttention Deficit and Disruptive Behavior DisordersNCT02305134Chiba University21
招募中
3 期
Tipeptidine as adjuvant therapy in children with ADHDDisturbance of activity and attention.Attention-deficit hyperactivity disorder, combined typeIRCT20090117001556N108Tehran University of Medical Sciences50
尚未招募
Unknown
To asses thyroid profile in children with autism spectrum disorder and attention deficit hyperactivity disorder -a descriptive study.CTRI/2023/06/054005KIMSHEALTH TRIVANDRUM
已完成
不适用
Procedure Sedation With Dexmedetomidine in Children With Autism Spectrum Disorders During Magnetic Resonance ImagingAutism Spectrum DisorderNCT03597477Guangzhou Women and Children's Medical Center136